M. Serra

M. Buti, R. Andrade, F. Jorquera, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of selenium compounds on murine B16 melanoma cells and pigmented cloned pB16 cells

E. Sabbioni, M. Serra, B. Siwek, 2007, Archives of Toxicology.

HTLV-III ANTIBODIES IN DRUG ADDICTS IN SPAIN

M. Serra, V. Gimeno, J. Rodrigo, 1985, The Lancet.

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

X. Forns, J. Sánchez-Tapias, M. Romero-Gómez, 2010, The American Journal of Gastroenterology.

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression

C. Montoliu, J. Ampuero, M. Romero-Gómez, 2018, Journal of gastroenterology and hepatology.

Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

V. Felipo, E. Kosenko, C. Montoliu, 2018, Free radical research.

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

J. Ampuero, J. Calleja, J. Crespo, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

V. Felipo, C. Montoliu, M. Serra, 2007, Journal of Molecular Medicine.

Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.

L. Martí-Bonmatí, Á. Alberich-Bayarri, Ana Jiménez-Pastor, 2021, Radiology.

Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

V. Felipo, C. Montoliu, A. Urios, 2011, Metabolic Brain Disease.

Effects of trace metal compounds on HIV-1 reverse transcriptase

E. Sabbioni, M. Serra, K. Baricevic, 1999, Biological Trace Element Research.

Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis

M. Serra, J. Rodrigo, J. D. Del Olmo, 1998, Journal of Cancer Research and Clinical Oncology.

Increased protein kinase A regulatory subunit content and cGMP binding in erythrocyte membranes in liver cirrhosis.

V. Felipo, E. Kosenko, J. Calvete, 2004, Journal of hepatology.

Altered modulation of soluble guanylate cyclase in lymphocytes from patients with liver disease

V. Felipo, M. Miñana, M. Serra, 2002, Journal of Molecular Medicine.

Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis

J. González-Navajas, M. Serra, P. Zapater, 2008, Hepatology.

[The hepatitis C virus among the prison population of Valencia].

F. Llovet, M. Serra, J. Rodrigo, 1995, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

3-Nitro-Tyrosine as a Peripheral Biomarker of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis

V. Felipo, C. Montoliu, A. Urios, 2011, The American Journal of Gastroenterology.

Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do

S. Llerena, J. Calleja, J. Crespo, 2020, Journal of viral hepatitis.

[The time factor in the management of chronic hepatitis C].

M. Serra, 2008, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Is cognitive impairment in cirrhotic patients due to increased peroxynitrite and oxidative stress?

V. Felipo, C. Montoliu, D. Escudero-García, 2015, Antioxidants & redox signaling.

638 3-NITRO-TYROSINE AS A PERIPHERAL BIOMARKER OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS

V. Felipo, C. Carda, C. Montoliu, 2012 .

Prevalence and incidence of gallstones in liver cirrhosis.

M. Serra, J. Rodrigo, J. D. Del Olmo, 1997, Scandinavian journal of gastroenterology.

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study

J. Mallolas, M. Laguno, J. Losa, 2019, PloS one.

[A meta-analysis of controlled studies of the treatment of chronic hepatitis due to the hepatitis B virus].

M. Serra, J. Rodrigo, J. D. Del Olmo, 1991, Medicina clinica.

Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

V. Felipo, C. Montoliu, A. Urios, 2007 .

Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

Carmina Montoliu, Amparo Urios, Remedios Giner-Duran, 2012, Hepatology.

IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy

V. Felipo, C. Montoliu, A. Urios, 2009, Journal of clinical gastroenterology.

Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain

J. Lazarus, J. Llorca, S. Llerena, 2019, Journal of viral hepatitis.

Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis.

M. Serra, A. Benages, J A del Olmo, 2000, Journal of hepatology.

Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients.

F. J. Romero, F. Bosch-Morell, M. J. Romero, 1998, Free radical biology & medicine.

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

M. Serra, J. Rodrigo, J. D. Del Olmo, 2003, Journal of viral hepatitis.

Vanadate as an inhibitor of plant and mammalian peroxidases

E. Sabbioni, M. Serra, A. Pintar, 1989, Biological Trace Element Research.

Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro.

L. Casella, E. Sabbioni, M. Serra, 1992, Journal of inorganic biochemistry.

Prevalence of liver disease and infection by hepatitis B, Delta virus, and human immunodeficiency virus in two Spanish penitentiaries

F. Llovet, M. Serra, M. Bixquert, 2004, Medical Microbiology and Immunology.

Interferon decreases serum lipid peroxidation products of hepatitis C patients.

F. J. Romero, J. Romá, M. Serra, 1994, Free radical biology & medicine.

Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant

C. Solano, D. Navarro, M. Serra, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

Miguel A. Serra, Vicente Belloch, Mercedes Atienza, 2012, NeuroImage.

Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease.

M. Serra, J. Bagan, I. Pascual, 2000, European journal of oral sciences.

Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982–2003)

M. Serra, J. Rodrigo, J. D. Del Olmo, 2006, Journal of gastroenterology and hepatology.

Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

V. Felipo, C. Montoliu, A. Urios, 2012, Metabolic Brain Disease.

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.

M. Serra, B. Torondel, P. Lluch, 2004, Journal of hepatology.

Risk Factors for Nonhepatic Surgery in Patients with Cirrhosis

M. Serra, S. Lledó, B. Flor‐Lorente, 2003, World Journal of Surgery.

Digital pathology: accurate technique for quantitative assessment of histological features in metabolic‐associated fatty liver disease

L. Martí-Bonmatí, Á. Alberich-Bayarri, A. Rodríguez-Ortega, 2020, Alimentary pharmacology & therapeutics.

Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.

M. Buti, J. Lazarus, X. Forns, 2022, Gastroenterologia y hepatologia.

Effect of Hepatitis C Virus Infection and Abstinence From Alcohol on Survival in Patients With Alcoholic Cirrhosis

M. Serra, J. Rodrigo, J. D. Del Olmo, 2003, Journal of clinical gastroenterology.

Nickel-induced proteins in human HaCaT keratinocytes: annexin II and phosphoglycerate kinase.

F. Acevedo, M. Serra, O. Vesterberg, 2001, Toxicology.

Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies.

D. Monleón, M. Serra, B. Celda, 2010, International journal of molecular medicine.

Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

V. Felipo, E. Kosenko, C. Montoliu, 2022, Scientific Reports.

Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

V. Felipo, E. Kosenko, C. Montoliu, 2022, Scientific reports.

Liver cirrhosis and diabetes mellitus.

M. Serra, J. Rodrigo, J. D. Del Olmo, 1996, Journal of hepatology.

Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease

N. Chatauret, R. Butterworth, V. Felipo, 2004, Neurochemistry International.

Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.

V. Felipo, A. Pineda-Lucena, C. Montoliu, 2010, Journal of proteome research.

Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.

Manuel Romero-Gómez, Rodrigo Jover, C. Montoliu, 2015, Gastroenterology.

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System.

M. Buti, H. Razavi, J. Calleja, 2017, Medicina clinica.

Prevalence of hepatitis C in the spanish population. The prevhep study (ethon cohort)

S. Llerena, J. Calleja, M. Serra, 2017 .

Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease

L. Martí-Bonmatí, Á. Alberich-Bayarri, D. Escudero-García, 2021, Biomolecules.

Accumulation of Symmetric Dimethylarginine in Hepatorenal Syndrome

M. Serra, M. Mauricio, P. Lluch, 2006, Experimental biology and medicine.

Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis

M. Puchades, M. Serra, A. Wassel, 2004, Scandinavian journal of gastroenterology.

Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation.

L. Martí-Bonmatí, M. Serra, A. Ferrández, 1993, Radiology.

Oral lichen planus and hepatic cirrhosis.

M. Serra, J. Bagan, M. Bixquert, 1989, Annals of internal medicine.

Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis.

F. Jorquera, R. Quiles, M. Diago, 2015, World journal of gastroenterology.

Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28−, Th22 and Tfh and B lymphocytes

V. Felipo, C. Montoliu, D. Escudero-García, 2017, Scientific Reports.

Reduced white matter microstructural integrity correlates with cognitive deficits in minimal hepatic encephalopathy

C. Forn, C. Ávila, J. García-Panach, 2013, Gut.

589 PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY SHOW IMPAIRED MISMATCH NEGATIVITY CORRELATING WITH REDUCED PERFORMANCE IN ATTENTION TESTS

V. Felipo, C. Montoliu, A. Urios, 2013 .

Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis

Carmina Montoliu, Vicente Felipo, V. Felipo, 2005, Liver international : official journal of the International Association for the Study of the Liver.

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?

J. Górriz, N. Panizo, Lorena Gandía, 2021, International journal of environmental research and public health.

Immune response to hepatitis B vaccine in parenteral drug abusers.

M. Serra, A. Artero, A. Wassel, 1992, Vaccine.

Unchanged plasma levels of dimethylarginines and nitric oxide in chronic hepatitis C

M. Serra, M. Mauricio, P. Lluch, 2009, Scandinavian journal of gastroenterology.

A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A.

V. Felipo, C. Montoliu, M. Serra, 2007, American journal of physiology. Gastrointestinal and liver physiology.

Altered Modulation of Soluble Guanylate Cyclase by Nitric Oxide in Patients with Liver Disease

V. Felipo, M. Miñana, C. Montoliu, 2002, Metabolic Brain Disease.

Design and cost effectiveness of a hepatitis C virus elimination strategy based on an updated epidemiological study (ETHON cohort)

S. Llerena, D. Escudero-García, M. Serra, 2018 .

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

M. Buti, F. Jorquera, J. Calleja, 2015, Annals of hepatology.

Pegylated α‐interferon‐2a plus ribavirin compared with pegylated α‐interferon‐2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non‐randomized study

M. Serra, J. Rodrigo, J. D. Del Olmo, 2008, Journal of gastroenterology and hepatology.

[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients].

M. Buti, M. Serra, I. Oyagüez, 2014, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.

M. Buti, J. Lazarus, X. Forns, 2022, Gastroenterologia y hepatologia.

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

M. Buti, I. Carmona, D. Escudero-García, 2022, Gastroenterologia y hepatologia.

Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

V. Felipo, M. Atienza, C. Montoliu, 2012, NeuroImage.

Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.

V. Felipo, C. Montoliu, V. Belloch, 2014, World journal of gastroenterology.

The discriminant diagnostic power of liver function tests in hepatic cirrhosis.

M. Serra, M. Bixquert, A. Wassel, 1981, Acta medica portuguesa.

Effects of Isoflurane on Liver Function

F. Pallardó, J. Viña, J. Llopis, 1986 .